Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Revista colombiana de Gastroenterología
versión impresa ISSN 0120-9957versión On-line ISSN 2500-7440
Resumen
SANCHEZ-PARDO, Santiago et al. The behavior of liver diseases in a cohort of Colombian patients with COVID-19. Rev. colomb. Gastroenterol. [online]. 2022, vol.37, n.2, pp.193-199. Epub 24-Ago-2022. ISSN 0120-9957. https://doi.org/10.22516/25007440.853.
Introduction:
Severe acute respiratory syndrome type 2 coronavirus infection (SARS-CoV-2) is receiving the most attention now. The asymptomatic elevation of transaminases is typical in the liver, and liver involvement varies from 14 % to 78 %. The assessment of liver comorbidities is scarce, with prevalence ranging between 2 % and 11 %.
Aim:
To describe the behavior of a cohort of patients with liver diseases who fell ill with coronavirus disease 2019 (COVID-19).
Materials and methods:
This retrospective observational study analyzed the behavior of a cohort of patients with liver diseases who fell ill with COVID-19.
Results:
543 patients became ill with COVID-19, of which 300 were women (55.3 %). The median age at diagnosis of liver disease was 52 years. The leading causes of liver disease were nonalcoholic steatohepatitis (49.5 %), cholestatic disease (7.7 %), and hepatitis C and B viruses (6.3 %). Alanine aminotransferase (ALT) had a median of 52 U/L (interquartile range [IQR]: 30-98) and aspartate aminotransferase (AST) 32 U/L (IQR: 23-62). Mortality due to viral infection was 5.7 %, with an incidence rate of 2.9 (95 % confidence interval [CI]: 2-4.2).
Conclusions:
It is a retrospective study but, until the preparation of the manuscript, it had been the first cohort in Colombia to describe the behavior of liver diseases in patients who become ill with COVID-19. No statistically significant differences were found between the causes of liver disease that confer a higher risk of mortality; however, having decompensated cirrhosis is the only condition related to mortality.
Palabras clave : Fatty liver; SARS virus; cirrhosis of the liver; mortality.